XML 34 R23.htm IDEA: XBRL DOCUMENT v3.26.1
INVESTMENT IN DEBT AND EQUITY SECURITIES (Tables)
 9 Months Ended
Jan. 31, 2026
Schedule of activity for the notes and warrants
   
Balance of Femasys Note as of April 30, 2025  $3,696,000 
Change in fair value   1,304,000 
Settlement of Femasys Note   (5,000,000)
Balance of Femasys Note as of January 31, 2026  $– 

 

Balance of Femasys Warrant Asset as of April 30, 2025  $3,061,000 
Change in fair value   (2,155,000)
Balance of Femasys Warrant Asset as of January 31, 2026  $906,000 
Schedule of marketable equity securities
         
   Carrying Value      
   At Fair Market  Adjusted  Unrealized
Marketable securities   Value    Cost Basis    Loss 
                
Equity – stock  $372,251   $666,316   $294,065 
Schedule of activity preferred stock
   
Balance of Series G Preferred Stock as of April 30, 2025  $22,474,000 
Change in fair value   (5,127,000)
Balance of Series G Preferred Stock as of January 31, 2026  $17,347,000 

 

Below is a summary of activity for the QCLS Warrants as of January 31, 2026:

    
Balance of QCLS Series G Warrant assets as of April 30, 2025  $8,618,000 
Change in fair value   (1,652,000)
Balance of QCLS Series G Warrant assets as of January 31, 2026  $6,966,000 
Series H Preferred Stock [Member]  
Schedule of activity preferred stock
   
Balance of Series H Preferred Stock as of April 30, 2025  $– 
Initial fair value of investment Series H Preferred Shares   3,483,000 
Change in fair value   1,642,000 
Balance of Series H Preferred Stock as of January 31, 2026  $5,125,000 

 

Below is a summary of activity for the QCLS Series H Warrants as of January 31, 2026:

    
Balance of QCLS Series H Warrant assets as of April 30, 2025  $– 
Initial fair value of investment in of QCLS Series H Warrants   1,606,000 
Change in fair value   1,670,000 
Balance of QCLS Series H Warrant assets as of January 31, 2026  $3,276,000